Lymphangioma medical therapy: Difference between revisions
Jump to navigation
Jump to search
Badria Munir (talk | contribs) No edit summary |
Badria Munir (talk | contribs) No edit summary |
||
Line 1: | Line 1: | ||
<ref name="pmid5556746">{{cite journal |vauthors=Rajasingham R, Bell JL, Baron DN |title=A comparative study of the isoenzymes of mammalian alpha-amylase |journal=Enzyme |volume=12 |issue=2 |pages=180–6 |date=1971 |pmid=5556746 |doi= |url=}}</ref>__NOTOC__ | <ref name="pmid5556746">{{cite journal |vauthors=Rajasingham R, Bell JL, Baron DN |title=A comparative study of the isoenzymes of mammalian alpha-amylase |journal=Enzyme |volume=12 |issue=2 |pages=180–6 |date=1971 |pmid=5556746 |doi= |url=}}</ref> | ||
__NOTOC__ | |||
{{Lymphangioma}} | {{Lymphangioma}} | ||
{{CMG}} {{AE}} {{HL}} | {{CMG}} {{AE}} {{HL}} | ||
Line 10: | Line 12: | ||
* Sodium tetradecyl sulfate is an off lable option for treatment of lymphangioma circumscriptum.<ref name="pmid1524">{{cite journal |vauthors=Moos F, Richard P, Sugiura M, Iwasaki K, Kato R |title=[Adrenergic and cholinergic control of oxytocin release evoked by vaginal, vagal and mammary stimulation in lactating rats (author's transl)] |language=French |journal=J. Physiol. (Paris) |volume=70 |issue=3 |pages=315–32 |date=November 1975 |pmid=1524 |doi= |url=}}</ref> | * Sodium tetradecyl sulfate is an off lable option for treatment of lymphangioma circumscriptum.<ref name="pmid1524">{{cite journal |vauthors=Moos F, Richard P, Sugiura M, Iwasaki K, Kato R |title=[Adrenergic and cholinergic control of oxytocin release evoked by vaginal, vagal and mammary stimulation in lactating rats (author's transl)] |language=French |journal=J. Physiol. (Paris) |volume=70 |issue=3 |pages=315–32 |date=November 1975 |pmid=1524 |doi= |url=}}</ref> | ||
Other Therapies include:<ref name="pmid5556746">{{cite journal |vauthors=Rajasingham R, Bell JL, Baron DN |title=A comparative study of the isoenzymes of mammalian alpha-amylase |journal=Enzyme |volume=12 |issue=2 |pages=180–6 |date=1971 |pmid=5556746 |doi= |url=}}</ref> | ===== Other Therapies include:<ref name="pmid5556746">{{cite journal |vauthors=Rajasingham R, Bell JL, Baron DN |title=A comparative study of the isoenzymes of mammalian alpha-amylase |journal=Enzyme |volume=12 |issue=2 |pages=180–6 |date=1971 |pmid=5556746 |doi= |url=}}</ref> ===== | ||
*Destructive treatments with carbon dioxide (CO2) laser | *Destructive treatments with carbon dioxide (CO2) laser | ||
* | *Long-pulsed Nd-YAG laser | ||
* Electrosurgery | |||
* Cryotherapy | |||
sclerotherapy with 23.4% hypertonic saline | * Superficial radiotherapy sclerotherapy with 23.4% hypertonic saline | ||
* Direct injection of a sclerosing agent, including 1% or 3% sodium tetradecyl sulfate, doxycycline or ethanol | |||
==References== | ==References== |
Revision as of 23:14, 16 October 2018
Lymphangioma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Lymphangioma medical therapy On the Web |
American Roentgen Ray Society Images of Lymphangioma medical therapy |
Risk calculators and risk factors for Lymphangioma medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Haytham Allaham, M.D. [2]
Overview
- There is no particular medical treatment for lymphangioma; the mainstay of therapy is surgery.
Medical Therapy
There is no medical treatment for lymphangioma; the mainstay of therapy is surgery.
- However propranolol is a potential option, which can be used in intractable lymphangiomatosis.[2]
- Sodium tetradecyl sulfate is an off lable option for treatment of lymphangioma circumscriptum.[3]
Other Therapies include:[1]
- Destructive treatments with carbon dioxide (CO2) laser
- Long-pulsed Nd-YAG laser
- Electrosurgery
- Cryotherapy
- Superficial radiotherapy sclerotherapy with 23.4% hypertonic saline
- Direct injection of a sclerosing agent, including 1% or 3% sodium tetradecyl sulfate, doxycycline or ethanol
References
- ↑ 1.0 1.1 Rajasingham R, Bell JL, Baron DN (1971). "A comparative study of the isoenzymes of mammalian alpha-amylase". Enzyme. 12 (2): 180–6. PMID 5556746.
- ↑ Sack M, Cassidy JT, Bole GG, Vinar O (December 1975). "Prognostic factors in polyarteritis". J. Rheumatol. 2 (4): 411–20. PMID 1533.
- ↑ Moos F, Richard P, Sugiura M, Iwasaki K, Kato R (November 1975). "[Adrenergic and cholinergic control of oxytocin release evoked by vaginal, vagal and mammary stimulation in lactating rats (author's transl)]". J. Physiol. (Paris) (in French). 70 (3): 315–32. PMID 1524.